Connect Education Workshop Details
Help
Advances in the Treatment of Head and Neck Cancer
Terry A. Day, MD, FACS Director, Head & Neck Tumor Program, Hollings Cancer Center, Professor and Director, Division of Head and Neck Oncologic Surgery, Medical University of South Carolina |
|
William M. Lydiatt, MD Professor and Vice Chair, Department of Otolaryngology, Director of Head and Neck Surgery, University of Nebraska Medical Center |
|
Marshall R. Posner, MD Medical Director, Head and Neck Oncology Program, Dana-Farber Cancer Institute |
|
David I. Rosenthal, MD, FACR Professor, Section Chief, Head and Neck Radiation Oncology, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center |
|
Douglas E. Peterson, DMD, PhD Chair, Program in Head & Neck Cancer and Oral Oncology, Neag Comprehensive Cancer Center, University of Connecticut Health Center |
|
Jan S. Lewin, PhD Professor, Department of Head and Neck Surgery, Director, Section of Speech Pathology and Audiology, The University of Texas MD Anderson Cancer Center |
|
Denise Anderson, MS, RD, LD Senior Clinical Dietitian, The University of Texas MD Anderson Cancer Center, Department of Clinical Nutrition |
|
Carolyn Messner, DSW, MSW Director of Education and Training, CancerCare |
|
American Cancer Society, American Pain Foundation, American Society of Clinical Oncology, Association of Clinicians for the Underserved, Association of Oncology Social Work, Black Women's Health Imperative, Cancer Patient Education Network, Cancer Support Community, Education Network to Advance Cancer Clinical Trials, Head and Neck Cancer Alliance, Intercultural Cancer Council, Joe's House, Multinational Association of Supportive Care in Cancer, National Black Leadership Initiative on Cancer, National Center for Frontier Communities, National Coalition for Cancer Survivorship, National Family Caregivers Association, Oral Cancer Foundation, Research Advocacy Network, Support for People with Oral and Head and Neck Cancer, Vital Options International & The Group Room
...a charitable contribution from Bristol-Myers Squibb and ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company.
April 16, 2010
